Treatment with cannflavin A at 2.5 μM for 24 h, whilst not affecting bladder cancer cell viability, was able to induce caspase 3 cleavage, suggesting it could affect bladder cancer cell apoptosis. The gene discussed is CASP3; the disease is urinary bladder carcinoma.